Related Experiment Videos
Clinical observations with long-term atrial pacing
1Cardiovascular Center, Imre Haynal University of Health Sciences, Budapest, Hungary.
Pacing and Clinical Electrophysiology : PACE
|February 25, 1998
Summary
Atrial pacing (AP) is a safe and effective treatment for sick sinus syndrome (SSS), offering long-term antiarrhythmic benefits. Careful patient selection is key to preventing conduction disturbances and ensuring optimal outcomes with AP.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Atrial pacing (AP) provides hemodynamic and antiarrhythmic benefits but remains underutilized.
- Sick sinus syndrome (SSS) encompasses bradycardia and tachycardia-bradycardia syndromes, often requiring pacing.
- Long-term outcomes of AP in SSS patients require further evaluation.
Purpose of the Study:
- To assess the long-term efficacy and safety of atrial pacing in patients with sick sinus syndrome.
- To evaluate the antiarrhythmic effects and impact on quality of life.
- To identify factors influencing the development of conduction disturbances.
Main Methods:
- A retrospective study of 64 patients with SSS treated with AP between 1982-1996.
- Patients were selected based on specific criteria, including absence of AV block and adequate atrial function.
- Follow-up evaluations were conducted every 3-6 months, with a mean follow-up of 67 months.
Main Results:
- All 33 patients with sinus bradycardia (SB) maintained sinus rhythm without developing AV block.
- Among 27 patients with tachycardia-bradycardia syndrome (TBS), 20 achieved significant reduction in paroxysmal attacks, improving quality of life.
- Seven TBS patients developed chronic atrial fibrillation, with 3 experiencing cerebral embolism; 3 had temporary AV block that resolved with medication adjustment.
Conclusions:
- Atrial pacing is a safe and reliable long-term treatment for sick sinus syndrome.
- Proper patient selection is critical for preventing AV conduction disturbances.
- Atrial pacing demonstrates a satisfactory long-term antiarrhythmic effect in SSS patients.